It seems to me the question of credibility as regards Resverlogix is twofold.  There's the scientific side and then the corporate.  

While the credibility of Apabetalone has been increasing from the scientific side, on the corporate side I don't know that there's any left.  

From the cancelation of the AGM wiith no explanation ever given as to the reasons why, to the publication and presentation of financial info with the wrong debt level and share count.  And I still haven't forgotten the Paris event that they decided to pass on without a word to investors, not about the decision to not attend before the fact, or an explanation as to why afterwards.

Its almost like for every scientific event that increases the scientific credibility of Apabetalone, like a positive reccomendation from the DSMB, its almost like they feel compelled to do something to diminish the credibility of the management side.   

I think that might be intentional....Monday if nothing is out at the opening bell, it might lead some to bail out perhaps...of course if some do decide to bail there has to be someone on the other side of the trade willing to buy.  Someone who obviously isn't as worried about the seeming lack of corporate credibility.